Company research / INSM

INSMED Inc (INSM)

CIK 0001104506 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated VA
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, INSMED Inc reported revenue of $606.42M. Revenue grew 66.7% from the prior annual period.

Key ratios (year ended 2025-12-31)

-205.6%
Operating margin
-210.5%
Net margin
-172.8%
Return on year-end equity
66.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-08-19

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.